Table 3.
Parameter estimates from regression models for abnormal mood state versus reduced sleep.
| Abnormal Mood State | Reduced Sleep | % | |
|---|---|---|---|
| TNF-α | 18.5 | 13.0 | 70% |
| sTNF-R1 | 18.4 | 11.1 | 61% |
| sTNF-R2 | 22.2 | 13.9 | 63% |
| IL-1β | 17.7 | 14.8 | 84% |
| IL-6 | 18.3 | 15.2 | 83% |
| IL-10 | 16.0 | 12.5 | 78% |
| IL-18 | 19.2 | 13.9 | 73% |
| IL-4 | 16.9 | 10.4 | 62 % |
| IL-17 | 10.2 | 8.2 | 81% |
| IFN-β | 15.1 | 13.0 | 86% |
| IL-1RA | 9.5 | 7.1 | 75% |
| IL-18-BP | 14.0 | 9.6 | 68% |
| MCP-1 | 20.9 | 21.1 | 101% |
| FGF-β | 19.4 | 16.2 | 83% |
| VEGF | 19.2 | 14.8 | 77% |
| BDNF | 9.7 | 3.2 | 33% |
| TGF-β | 13.4 | 10.4 | 77% |
All models were adjusted for age, gender, current smoking, and BMI and include either the original indicator variable for an abnormal mood state or an indicator for reduced sleep. In all but one model, the parameter estimates for the reduced sleep indicator were of lower magnitude.